BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 8828070)

  • 1. [Pharmacokinetic, bacteriological and clinical studies on cefozopran in neonates and premature infants. A study of cefozopran in the perinatal co-research group].
    Fujii R; Okuno A; Fujita K; Kakuya F; Maruyama S; Sakata H; Inyaku F; Abe T; Hashira S; Nakazato Y; Sugiura M; Tajima T; Nagai S; Funamoto N; Sugimori S; Nishimura S; Yoshimura K; Kondoh Y; Kawaoi Y; Terashima I; Meguro H; Takeuchi Y; Kantake M; Sunakawa K; Yagisawa M
    Jpn J Antibiot; 1996 Jul; 49(7):678-702. PubMed ID: 8828070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and clinical effects of cefozopran in pediatric patients.
    Fujii R; Abe T; Tajima T; Terashima I; Meguro H
    Jpn J Antibiot; 1996 Jan; 49(1):17-33. PubMed ID: 8851304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fundamental and clinical evaluation of cefozopran in low birth weight infants and neonates].
    Sato Y; Sunakawa K; Akita H; Iwata S; Yokota T; Kusumoto Y
    Jpn J Antibiot; 1997 Dec; 50(12):917-35. PubMed ID: 9545669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetic and clinical studies with cefozopran in the pediatric field. Pediatric Study Group of Cefozopran].
    Fujii R; Abe T; Tajima T; Terashima I; Meguro H; Nakazawa S; Sato H; Niinou K; Sunakawa K; Yokota T
    Jpn J Antibiot; 1994 Jan; 47(1):102-23. PubMed ID: 8114268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Optimum dose study of cefozopran in the pediatric field].
    Fujii R; Sunakawa K; Sato Y; Yokota T; Yoshimura K; Kondoh Y; Kawaoi Y; Terashima I; Meguro H; Niinou K; Toyonaga Y; Ishihara T; Iwai N; Nakamura H; Kuno K; Miyajima Y; Sakurai M; Itoh M; Kawasaki H; Suga S; Kamiya H; Fujiwara T; Inui T; Taniguchi K; Nakayama M
    Jpn J Antibiot; 1996 Jul; 49(7):663-77. PubMed ID: 8828069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetic, bacteriological and clinical studies on cefozopran in neonates].
    Abe T; Sugiura M; Nakazato Y; Hashira S; Yoshimura K; Kondoh Y; Kawaoi Y; Tajima T; Nagai S; Funamoto N; Sugimori S; Nishimura S
    Jpn J Antibiot; 1997 Dec; 50(12):936-44. PubMed ID: 9545670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetic and clinical evaluation of cefozopran in premature and newborn patients].
    Motohiro T; Sakata Y; Nagai K; Morita J; Takagishi T; Matsuo Y; Hashimoto T; Yoshinaga Y; Hayashi M; Toyota A; Fujimoto T; Wada M; Kamizono S
    Jpn J Antibiot; 1997 Dec; 50(12):953-66. PubMed ID: 9545672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetic, bacteriological and clinical studies on cefozopran in neonates].
    Meguro H; Terashima I; Takeuchi Y; Kantake M
    Jpn J Antibiot; 1997 Dec; 50(12):945-52. PubMed ID: 9545671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetic, bacteriological and clinical studies on cefozopran in the pediatric field].
    Motohiro T; Handa S; Yamada S; Sasaki H; Oki S; Yoshinaga Y; Oda K; Aramaki M; Sakata Y; Yamashita F
    Jpn J Antibiot; 1994 Nov; 47(11):1589-611. PubMed ID: 7853690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetics and clinical studies on aztreonam in neonates and premature infants (the first report). Study on effectiveness and safety in mono-therapy with aztreonam. A study of aztreonam in the Perinatal Co-research Group].
    Fuji R; Hashira S; Tajima T; Meguro H; Abe T; Sakata H; Kakehashi H; Fujita K; Murono K; Kaeriyama M
    Jpn J Antibiot; 1990 Mar; 43(3):543-62. PubMed ID: 2197468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetic and clinical studies on cefozopran in the field of pediatrics].
    Kaino Y; Kida K; Matsuda H
    Jpn J Antibiot; 1994 Nov; 47(11):1565-75. PubMed ID: 7853687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetic and clinical evaluations of aztreonam monotherapy and aztreonam and ampicillin combination therapy in neonates and premature infants].
    Motohiro T; Oda K; Aramaki M; Kawakami A; Tanaka K; Koga T; Shimada Y; Tomita S; Sakata Y; Tominaga K
    Jpn J Antibiot; 1990 Mar; 43(3):503-23. PubMed ID: 2374300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetics and clinical studies on flomoxef in neonates and premature infants. A study of flomoxef in the perinatal collaboration research group].
    Fujii R; Fujita K; Murono K; Saijo M; Kakuya F; Yoshioka H; Maruyama S; Sakata H; Hiramoto A; Inyaku F
    Jpn J Antibiot; 1993 Jul; 46(7):518-38. PubMed ID: 8371489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetic and clinical studies on the use of ceftizoxime in premature and newborn infants. The Chemotherapy Research Group for Mother and Child].
    Fujii R; Yoshioka H; Osano M; Nakazawa S; Hori M; Iwai N; Nishimura T; Kobayashi Y; Motohiro T; Yura J
    Jpn J Antibiot; 1988 Aug; 41(8):1030-45. PubMed ID: 3050188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetic, bacteriological and clinical studies on cefozopran in children].
    Tajima T; Kondo Y; Negishi S; Kawashima S; Hagiwara N; Iizuka T; Kubota K; Abe T
    Jpn J Antibiot; 1994 Nov; 47(11):1457-63. PubMed ID: 7853676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetic and clinical evaluation of cefozopran in the pediatric field].
    Toyonaga Y; Ishihara T; Hatakeyama K; Sano T; Kawamura K; Seo K; Nakamura H
    Jpn J Antibiot; 1994 Nov; 47(11):1495-513. PubMed ID: 7853680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetic and clinical evaluation of cefozopran in newborn patients].
    Tsuji Y; Fukuda M; Tomimasu K; Yoshinaga M; Takayanagi T; Nakashita S; Kusumoto T; Tanaka H; Hayashi K
    Jpn J Antibiot; 1997 Dec; 50(12):967-74. PubMed ID: 9545673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on cefozopran in the pediatric field].
    Niinou K; Sato H
    Jpn J Antibiot; 1994 Nov; 47(11):1473-84. PubMed ID: 7853678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacokinetics and clinical evaluation of ceftriaxone in neonates].
    Fujii R; Hashira S; Sakata H; Inyaku F; Fujita K; Maruyama S; Yoshioka H; Nakazawa S; Satoh H; Narita A
    Jpn J Antibiot; 1988 Sep; 41(9):1237-50. PubMed ID: 3071615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetic and clinical studies on cefozopran in pediatrics].
    Akita H; Sato Y; Iwata S; Yokota T; Sunakawa K
    Jpn J Antibiot; 1994 Nov; 47(11):1485-94. PubMed ID: 7853679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.